Skip to content

Verifying Remote Monitoring Effect on Net Cardiovascular Outcome; RemoteVerify (RêVe)

Prospective Multicenter Observation Study on the Association Between Remote Monitoring and Clinical Outcome in Heart Failure Patients (Verifying Remote Monitoring Effect on Net Cardiovascular Outcome; RemoteVerify (RêVe))

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05971225
Acronym
ReVe
Enrollment
450
Registered
2023-08-02
Start date
2023-11-11
Completion date
2027-04-30
Last updated
2024-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Resynchronization Therapy, Congestive Heart Failure, Defibrillators

Keywords

remote monitoring, congestive heart failure, Defibrillators, cardiac resynchronization therapy

Brief summary

This study investigates the impact and safety of wireless monitoring on the prognosis of heart failure patients with implanted pacemakers and defibrillators. It aims to examine the frequency of unplanned early hospital visits and the early diagnosis/intervention of disease exacerbation based on the presence or absence of wireless monitoring. Additionally, the study analyzes the influence of wireless monitoring on the patient's disease progression as well as satisfaction of the study participants.

Interventions

remote monitoring only can replace in-office device monitoring

Sponsors

Biotronik SE & Co. KG
CollaboratorINDUSTRY
Saint Vincent's Hospital, Korea
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

one group with experience of in-office device monitoring \>6 months the other group without experience of in-office device monitoring

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* consented heart failure patients (LVEF\<=40%) with Biotronik wireless monitoring capable ICD/CRTs aged \>20 years * patients who are new to remote monitoring

Exclusion criteria

* For patients with a life expectancy of less than 6 months. If patient do not understand the contents of wireless monitoring or it is difficult to fill out the consent form due to cognitive decline. If wireless monitoring is performed with a patient enrolled in another clinical trial which remote monitoring may affect the previous enrolled study.

Design outcomes

Primary

MeasureTime frameDescription
Unplanned early visits for cardiac causes4 (Clinic)24monthsii. Hospitalization/Admission due to alerts on the implanted cardiac device following wireless monitoring -\> Clinician-driven early visits
Unplanned early visits for cardiac causes3 (Patient)18monthsi. Unplanned hospitalization/admission due to patient's condition changes -\> Patients' needs-driven early visits
Unplanned early visits for cardiac causes4 (Patient)24monthsi. Unplanned hospitalization/admission due to patient's condition changes -\> Patients' needs-driven early visits
Unplanned early visits for cardiac causes1 (Clinic)6monthsii. Hospitalization/Admission due to alerts on the implanted cardiac device following wireless monitoring -\> Clinician-driven early visits
Unplanned early visits for cardiac causes2 (Clinic)12monthsii. Hospitalization/Admission due to alerts on the implanted cardiac device following wireless monitoring -\> Clinician-driven early visits
Unplanned early visits for cardiac causes3 (Clinic)18monthsii. Hospitalization/Admission due to alerts on the implanted cardiac device following wireless monitoring -\> Clinician-driven early visits
Unplanned early visits for cardiac causes1 (Patient)6 monthsi. Unplanned hospitalization/admission due to patient's condition changes -\> Patients' needs-driven early visits
Unplanned early visits for cardiac causes2 (Patient)12monthsi. Unplanned hospitalization/admission due to patient's condition changes -\> Patients' needs-driven early visits

Secondary

MeasureTime frameDescription
Cardiac-related deaths6,12,18,24 monthsCardiac cause deaths
Overall mortality6,12,18,24 monthsoverall deaths
Acute myocardial infarction (heart attack) or cerebrovascular events (stroke)6,12,18,24 monthsACS, CVA
Thromboembolic events (such as pulmonary embolism)6,12,18,24 monthsSystemic thromboembolic events
Worsening of heart failure leading to hospitalization6,12,18,24 monthsHF related admission

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026